March 8, 2021

Grifols fosters world’s first scientific journal specialized in blood plasma

  • Plasmatology aims to become the reference publication for plasma science, bringing together the discipline’s knowledge, research and scientific advances that until now lacked a specialized journal
  • The prestigious Publisher SAGE Publications, specializing in scientific journals, independently edits the new international, open access, peer-reviewed online publication, which debuts March 9

Barcelona, Spain, March 8, 2021 - Grifols (MCE: GRF, MCE: GRF.P y NASDAQ: GRFS), a global leader in plasma-derived therapies with a more than 100-year track record of contributing to the health and well-being of people, today announced it’s fostering the first scientific journal dedicated to the science of plasma, coinciding with the 70th anniversary of the international presentation of the plasmapheresis technique.

This procedure, which separates plasma from the other blood components that are then reinfused into the donor, was developed by Josep Antonio Grifols i Lucas in 1951 in Barcelona and today continues to be the gold standard for plasma collection globally.

Plasmatology, which begins publishing March 9, aspires to become the scientific reference in its field, featuring all relevant research related to plasma science, from basic research to clinical application.

The publication is edited independently, with its editorial committee and director answering only to the prestigious publisher SAGE Publications , a longtime publisher of respected scientific journals covering different medical disciplines, life sciences, engineering, the humanities and other areas.

The international, open access, peer-reviewed journal will publish manuscripts evaluated and vetted by independent experts. Researchers can send their work – original articles, case studies, technical essays, reviews, editorials and comments – to the editorial board for its consideration. All content will be indexed in PubMed Central, as well as other scientific data bases.

Grifols, as part of its longstanding commitment to the scientific community, will provide the journal with an educational grant during the next two years to establish the publication as a global source for the scientific knowledge and research accomplishments in plasma science.

According to Víctor Grifols Deu, co-CEO of Grífols, “At Grifols we’re celebrating the creation of Plasmatology and we believe without a doubt it will accelerate the knowledge and research of proprietary plasma therapeutics.”

Raimon Grifols Roura, co-CEO of Grifols, added: “In addition it’s particularly gratifying that the birth of the publication coincides with the 70th anniversary of the development of plasmapheresis by my uncle Josep Antoni Grifols i Lucas. The company’s commitment to research and scientific publishing forms part of his legacy.”